SAMe prevents the induction of the immunoproteasome and preserves the 26S proteasome in the DDC-induced MDB mouse model

Experimental and Molecular Pathology

Volumn 88, Issue 3, 2010, Pages 353-362

  Bardag Gorce, Fawzia ^a   Oliva, Joan ^a   Li, Jun ^a   French, Barbara A ^a   French, Samuel W ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

26S proteasome; Immunoproteasome; Inflammatory response; Interferon gamma; Mallory Denk body; TNF alpha

Indexed keywords

1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER; 26S PROTEASOME; CELL PROTEIN; CYTOKERATIN; GAMMA INTERFERON RECEPTOR 1; IMMUNOPROTEASOME; LARGE MULTIFUNCTIONAL PROTEASE 2; LARGE MULTIFUNCTIONAL PROTEASE 7; MULTICATALYTIC ENDOPEPTIDASE COMPLEX LIKE 1; PROTEASOME; PROTEIN FAT10; PROTEINASE; S ADENOSYLMETHIONINE; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; UNCLASSIFIED DRUG; ATP DEPENDENT 26S PROTEASE; CYSTEINE PROTEINASE; DIETHYL 1,4 DIHYDRO 2,4,6 TRIMETHYL 3,5 PYRIDINEDICARBOXYLATE; DIETHYL 1,4-DIHYDRO-2,4,6-TRIMETHYL-3,5-PYRIDINEDICARBOXYLATE; DIHYDROPYRIDINE DERIVATIVE; FAT10 PROTEIN, MOUSE; KERATIN; LMP 2 PROTEIN; LMP-2 PROTEIN; LMP7 PROTEIN; MULTIENZYME COMPLEX; PRIMER DNA; PSMB10 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; LIVER CELL; MALLORY BODY; MALLORY DENK BODY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; UPREGULATION; ALCOHOL LIVER DISEASE; ANIMAL; C3H MOUSE; CELL INCLUSION; CHEMISTRY; DISEASE MODEL; DRUG EFFECT; GENETICS; LIVER; MALE; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; BASE SEQUENCE; CYSTEINE ENDOPEPTIDASES; DIHYDROPYRIDINES; DISEASE MODELS, ANIMAL; DNA PRIMERS; GENE EXPRESSION; INCLUSION BODIES; KERATINS; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MICE; MICE, INBRED C3H; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; S-ADENOSYLMETHIONINE; UBIQUITIN; UBIQUITINS;

EID: 77952554640     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.03.001     Document Type: Article

References (43)

1. Aki M., Shimbara N., Takahina M., Akiyama K., Kagawa S., Tamura T., Tanahashi N., Yoshimura T. Interferon-gamma induces different subunit organizations and functional diversity of proteasomes. J. Biochem. (Tokyo) 1994, 115:257-269.
2. Ara A.I., Xia M., Ramani K., Mato J.M., Lu S.C. S-adenosylmethionine inhibits lipopolysaccharide-induced gene expression via modulation of histone methylation. Hepatology 2008, 47(5):1655-1666.
3. Bardag-Gorce F., Yuan Q.X., Li J., French B.A., Fang C., Ingelman-Sundberg M., French S.W. The effect of ethanol-induced cytochrome P4502E1 on the inhibition of proteasome activity by alcohol. Biochem. Biophys. Res. Commun. 2000, 279:23-29.
4. Bardag-Gorce F., Venkatesh R., Li J., French B.A., French S.W. Hyperphosphorylation of rat liver proteasome subunits: the effects of ethanol and okadaic acid are compared. Life Sci. 2004, 75(5):585-597.
5. Bardag-Gorce F., French B.A., Nan L., Song H., Nguyen S.K., Yong H., Dedes J., French S.W. CYP2E1 induced by ethanol causes oxidative stress, proteasome inhibition and cytokeratin aggresome (Mallory body-like) formation. Exp. Mol. Pathol. 2006, 81(3):191-201.
6. Bardag-Gorce F., Dedes J., French B.A., Oliva J.V., Li J., French S.W. Mallory body formation is associated with epigenetic phenotypic change in hepatocytes in vivo. Exp. Mol. Pathol. 2007, 83:160-168.
7. Bardag-Gorce F., Oliva J., Villegas J., Fraley S., Amidi F., Li J., Dedes J., French B., French S.W. Epigenetic mechanisms regulate Mallory Denk body formation in the livers of drug-primed mice. Exp. Mol. Pathol. 2008, 84(2):113-121.
8. Belich M.B., Glynne R.J., Senger G., Sheer D., Trowsdale J. Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins. Curr. Biol. 1994, 4:769-776.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
10. Busse A., Kraus M., Na I.K., Rietz A., Scheibenbogen C., Driessen C., Blau I.W., Thiel E., Keilholz U. Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits. Cancer 2008, 112(3):659-670.
11. Chiu Y.H., Sun Q., Chen Z.J. E1-E2 activates both ubiquitin and FAT10. Mol. Cell 2007, 27:1014-1023.
12. Coux O., Tanaka K., Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 1996, 65:801-847.
13. Dong J., Ivascu C., Chang H.-D., Wu P., Angeli R., Maggi L., Eckhardt F., Tykocinski L., Haefliger C., Mowes B., Sieper J., Radbruch A., Annunziato F., Thiel A. IL-10 is excluded from the functional cytokine memory of human CD4 memory T lymphocytes. J. Immunol. 2007, 179(4):2389-2396.
14. Donohue T.M. The ubiquitin-proteasome system and its role in ethanol-induced disorders. Addict. Biol. 2002, 7(1):15-28.
15. Fan W., Cai W., Parimoo S., Lennon G.G., Weissman S.M. Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics 1996, 44:97-103.
16. Fuchs S.Y. The role of ubiquitin-proteasome pathway in oncogenic signaling. Cancer Biol. Ther. 2002, 1(4):337-341.
17. Groettrup M., Kraft R., Kostka S., Standera S., Stohwasser R., Kloetzel P.M. A third interferon-gamma-induced subunit exchange in the 20S proteasome. Eur. J. Immunol. 1996, 26(4):863-869.
18. Groettrup M., Standera S., Stohwasser R., Kloetzel P.M. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc. Natl. Acad. Sci. USA 1997, 94(17):8970-8975.
19. Hipp M.S., Kalveram B., Raasi S., Groettrup M., Schmidtke G. FAT10, a ubiquitin-independent signal for proteasomal degradation. Mol. Cell. Biol. 2005, 25:3483-3491.
20. Ho Y.K., Bargagna-Mohan P., Wehenkel M., Tanaka K., Ichihara A. LMP2-specific inhibitors: chemical genetic tools for proteasome biology. Chem. Biol. 2007, 14:419-430.
21. Kloetzel P.M. Antigen processing by the proteasome. Nat. Rev. Mol. Cell Biol. 2001, 2:79-187.
22. Lee C.G., Ren J., Cheong I.S.Y., Ban K.H.K., Ooi L.L.P.J., Tan S.Y., Kan A., Nuchprayoon I., Jin R., Lee K.-H., Choti M., Lee L.A. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene 2003, 22:2592-2603.
23. Li J., Bardag-Gorce F., Dedes J., French B.A., Oliva J., Amidi F., French S.W. S-adenosylmethionine prevents Mallory Denk body formation in drug-primed mice by inhibiting epigenetic memory. Hepatology 2008, 47:613-624.
24. Liu C.H., Goldberg A.L., Qiu X.B. New insights into the role of the ubiquitin-proteasome pathway in the regulation of apoptosis. Chang Gung Med. J. 2007, 30(6):469-479.
25. Lukasiak S., Schiller C., Oehlschlaeger P., Schmidtke G., Krause P., Legler D.F., Autschbach F., Schermachei P., Breuhahn K., Groettrup M. Pro inflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 2008, 27(46):6068-6074.
26. Nagao Y., French B.A., Cai Y., French S.W., Wan Y.J. Inhibition of PPAR alpha/RXR alpha-mediated direct hyperplasia pathways during griseofulvin-induced hepatocarcinogenesis. J. Cell. Biochem. 1998, 69(2):189-200.
27. Nan L., Wu Y., Bardag-Gorce F., Li J., French B.A., Wilson L.T., French S.W. The p105/50 NF-kB pathway is essential for Mallory body formation. Exp. Mol. Pathol. 2005, 78(3):198-206.
28. Oliva J., Bardag-Gorce F., French B.A., Li J., McPhaul L., Amidi F., Dedes J., Habibi A., Nguyen S., French S.W. Fat10 is an epigenetic marker for liver preneoplasia in a drug-primed mouse model of tumorigenesis. Exp. Mol. Pathol. 2008, 84:102-112.
29. Oliva J., Bardag-Gorce F., Li J., French B.A., French S.W. Mallory Denk body formation is associated with an increase of the immunoproteasome and a decrease of the 26S proteasome. FASEB J. 2009, 23. 741.2.
30. Oliva J., Bardag-Gorce F., Li J., French B.A., Nguyen S.K., Lu S.C., French S.W. Betaine prevents Mallory-Denk body formation in drug-primed mice by epigenetic mechanisms. Exp. Mol. Pathol. 2009, 86(2):77-86.
31. Paul S. Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches. Bioessays 2008, 30(11-12):1172-1184.
32. Raasi S., Schmidtke G., Groettrup M. The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J. Biol. Chem. 2001, 276:35334-35343.
33. Raasi S., Schmidtke G., deGiuli R., Groettrup M. A ubiquitin-like protein which is synergistically inducible by interferon-Α and tumor necrosis factor-Α. Eur. Immunol. 1999, 9:4030-4036.
34. Roomi M.W., Gaal K., Yuan Q.X., French B.A., Fu P., Bardag-Gorce F., French S.W. Preneoplastic liver cell foci induced by thioacetamide toxicity in drug primed liver. Exp. Mol. Pathol. 2006, 81:8-14.
35. Schmidtke G., Kalveram B., Groettrup M. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L. FEBS Lett. 2009, 583(3):591-594.
36. Schwartz A.L., Ciechanover A. Targeting proteins for destruction by the ubiquitin system: implications for human pathobiology. Annu. Rev. Pharmacol. Toxicol. 2009, 49:73-96.
37. Starkova N.N., Koroleva E.P., Rotanova T.V. Intracellular proteolysis: signals of selective protein degradation. Bioorg. Khim. 2000, 26(2):83-96.
38. Veal N., Hsieh C.L., Xiong S., Mato J.M., Lu S., Tsukamoto H. Inhibition of lipopolysaccharide-stimulated TNF-alpha promoter activity by S-adenosylmethionine and 5'-methylthioadenosine. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 287:G352-G362.
39. Yamano T., Mizukami S., Murata S., Chiba T., Tanaka K., Udono H. Hsh90-mediated as assembly of the 26S proteasome is involved in the major histocompatibility complex Class I antigen. J. Biol. Chem. 2008, 283:28060-28065.
40. Yuan Q.X., Marceau N., French B.A., Fu P., French S.W. Mallory body induction in drug-primed mouse liver. Hepatology 1996, 24(3):603-612.
41. Yuan Q.X., Nagao Y., French B.A., Wan Y.J., French S.W. Dexamethasone enhances Mallory body formation in drug-primed mouse liver. Exp. Mol. Pathol. 2000, 69(3):202-210.
42. Zatloukal K., French S.W., Stumptner C., Strnad P., Harada M., Toivola D.M., Cadrin M., Omary M.B. From Mallory to Mallory-Denk bodies: what, how and why?. Exp. Cell Res. 2007, 313(10):2033-2049.
43. Zhang D.W., Jeang K.-T., Lee C.G.L. P53 negatively regulates the expression of FAT10, a gene upregulated in various cancers. Oncogene 2006, 25:2318-2327.